While not yet on the U.S. market, clinical studies and longer-term outcomes in Europe indicate these have potential in treating presbyopia
Editors’ note: This article discusses technologies that are under investigation in the U.S. and are not yet approved for marketing. Investigators for Revision Optics declined comment; information on that inlay is derived from a literature/abstract search

For further information download pdf.